Lifetime costs and health outcomes of each policy option using societal perspective
| Patients eligible for intravenous alteplase | Patients not eligible for intravenous alteplase | |||
| Alteplase | Alteplase and EVT | Supportive care | EVT | |
| Costs (THB) | 637 600 | 848 700 | 547 000 | 721 300 |
| Life years (years) | 5.76 | 6.81 | 5.36 | 6.17 |
| QALYs (years) | 2.48 | 3.92 | 2.13 | 3.65 |
| Incremental costs (THB) | 211 100 | 174 300 | ||
| Incremental QALYs (years) | 1.44 | 1.52 | ||
| ICER per QALY gained (95% CI) | 146 800 (146 300 to 147 300) | 115 000 (114 200 to 116 000) | ||
EVT, endovascular treatment; ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life year(s); THB, Thai Baht.